Relatlimab
Relatlimab (BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM) . Relatlimab is often used with Nivoluma to treat advanced melanoma.
Product Specifications
CAS Number
1673516-98-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6306943-01 0.1 mL
Histone H2B (HIST1H2BK, HIST3H2BB, ID, HIST1H2BH, H2BFJ, Histone H2B type 1-H, Histone H2B.j) (MaxLight 750)
Sign In for Pricing
View Details MBS6306943-02 5x 0.1 mL
Histone H2B (HIST1H2BK, HIST3H2BB, ID, HIST1H2BH, H2BFJ, Histone H2B type 1-H, Histone H2B.j) (MaxLight 750)
Sign In for Pricing
View Details 
MBS6131671-01 0.1 mL
HINT1 (Histidine Triad Nucleotide-binding Protein 1, Adenosine 5'-monophosphoramidase, FLJ30414, FLJ32340, HINT, PKCI1, PKCI-1, PRKCNH1, Protein kinase C inhibitor 1, Protein Kinase C-interacting protein 1) (AP)
Sign In for Pricing
View Details